Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and ...

Retrieved on: 2021-05-26 12:22:30

Tags for this article:

Branches of biology

Biology

Medical specialties

Stem cells

Hematopoietic stem cell transplantation

Cell therapy

Hematopoietic stem cell

Stem-cell therapy

Immunodeficiency

Myelodysplastic syndrome

Bone marrow

Chronic granulomatous disease

Jasper Therapeutics Inc.

Click the tags to see associated articles and topics

Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and .... View article details on HISWAI: https://pipelinereview.com/index.php/2021052678250/Antibodies/Jasper-Therapeutics-Announces-New-Clinical-Trial-with-the-National-Institute-of-Allergy-and-Infectious-Diseases-to-Evaluate-JSP191-in-Chronic-Granulomatous-Disease.html

Excerpt

JSP191 is a first-in-class humanized monoclonal antibody in clinical development as a conditioning agent that clears hematopoietic stem cells from ...

Article found on: pipelinereview.com

View Original Article